Search clinical trials for: Open-Label Study
Total 119571 results
-
Innervate Radiopharmaceuticals LLC (Formerly: Illumina...Memorial Sloan Kettering Cancer Center; New Approaches to Neuroblastoma Therapy...Active, not recruiting
-
Chinese University of Hong KongCompleted
-
Lykos TherapeuticsCompletedPosttraumatic Stress Disorder (PTSD)Israel
-
Agenus Inc.SuspendedAdvanced MelanomaUnited States, Spain, United Kingdom, France, Germany, Switzerland, Belgium, Italy, Brazil, Russian Federation
-
Cassava Sciences, Inc.Active, not recruitingAlzheimer's DiseaseUnited States, Canada
-
Incyte Biosciences Japan GKCompleted
-
Neurocrine BiosciencesHuntington Study GroupActive, not recruitingChorea, HuntingtonUnited States, Canada
-
Mirum Pharmaceuticals, Inc.Completed
-
Sumitomo Pharma America, Inc.CompletedParkinson DiseaseUnited States, Spain, United Kingdom, Italy, Canada, Austria, France, Germany
-
AstraZenecaCompletedHypertensionUnited States
-
Zynerba Pharmaceuticals, Inc.Completed22Q Deletion SyndromeUnited States, Australia
-
Hoffmann-La RocheTerminatedCrohn DiseaseUnited States, Israel, Spain, United Kingdom, Canada, Australia, Austria, Czechia, France, Italy, Netherlands, New Zealand, Russian Federation, Belgium, Brazil, Korea, Republic of, Germany, Bulgaria, Croatia, Hungary, Poland, Ukraine and more
-
CelgeneCompletedLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-HodgkinFrance, Italy, Netherlands
-
Santen SASCompletedDry Eye Disease With Severe KeratitisCzechia, France, Italy, Poland, Russian Federation, Spain, Turkey
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNonsquamous Non-small Cell Lung CancerUnited States, Argentina, Australia, Canada, Chile, China, France, Germany, Israel, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Turkey, United Kingdom
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Germany, Spain, Denmark, Netherlands, Finland, Italy
-
Merck Sharp & Dohme LLCCompleted
-
AbbVieCompletedAtopic DermatitisUnited States, Australia, Canada, Croatia, Czechia, Finland, France, Germany, Hungary, Ireland, Israel, Italy, Malaysia, Netherlands, New Zealand, Norway, Poland, Singapore, Spain, Taiwan, Ukraine, United Kingdom
-
Merck Sharp & Dohme LLCCompletedSquamous Cell CarcinomaCanada, United States, Australia, France, Germany, Israel, Mexico, Norway, Spain, United Kingdom
-
M.D. Anderson Cancer CenterActive, not recruitingStage III Fallopian Tube Cancer AJCC v7 | Stage III Ovarian Cancer AJCC v6 and v7 | Stage III Primary Peritoneal Cancer AJCC v7 | Stage IIIA Fallopian Tube Cancer AJCC v7 | Stage IIIA Ovarian Cancer AJCC v6 and v7 | Stage IIIA Primary Peritoneal Cancer AJCC v7 | Stage IIIB Fallopian Tube Cancer... and other conditionsUnited States
-
Juntendo UniversityMerck Sharp & Dohme LLCActive, not recruitingNon-squamous Non-small-cell Lung Cancer | EGFR Activating MutationJapan
-
Dermavant Sciences, Inc.Completed
-
Merck Sharp & Dohme LLCCompletedCarcinoma, Non-Small-Cell LungUnited States, Ireland, Argentina, Australia, Brazil, Canada, Chile, Colombia, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Peru, Poland, South Africa, Spain, Taiwan, Thailand, Turkey, Ukraine, United Kingdom
-
SecuraBioTerminatedHead and Neck Squamous Cell CarcinomaUnited States
-
Rhythm Pharmaceuticals, Inc.Completed
-
Heat BiologicsCompletedNon-small Cell Lung CancerUnited States
-
BiocadActive, not recruitingClinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced MelanomaMelanoma (Skin)Russian Federation
-
Syndax PharmaceuticalsMerck Sharp & Dohme LLCCompletedMelanoma | Non-Small Cell Lung Cancer | Mismatch Repair-Proficient Colorectal CancerUnited States
-
Haukeland University HospitalBerGenBio ASAActive, not recruiting
-
Dermavant Sciences, Inc.Completed
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCTerminatedAdvanced Solid TumorsCanada, United States, Denmark, Israel, Switzerland
-
PfizerEmergent Product Development Seattle LLCCompletedRheumatoid ArthritisUnited States, Canada
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCActive, not recruiting
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada
-
MedivirActive, not recruitingHepatocellular Carcinoma | Intrahepatic Cholangiocarcinoma | Liver MetastasesKorea, Republic of, Spain, Belgium, United Kingdom
-
AmgenMerck Sharp & Dohme LLCCompletedRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)United States, Germany, Spain, Australia, Netherlands, France
-
Merck Sharp & Dohme LLCCompletedUrothelial Carcinoma Associated 1 RNA, Human
-
Eidos Therapeutics, a BridgeBio companyActive, not recruitingAmyloid Cardiomyopathy, Transthyretin-RelatedUnited States, Spain, Australia, Canada, Italy, Netherlands, Ireland, New Zealand, Belgium, Israel, Greece, Korea, Republic of, Czechia, Brazil, Denmark, Portugal, United Kingdom
-
AstraZenecaTerminatedNon-Hodgkin LymphomaSpain, United States, Korea, Republic of, France, Portugal, Australia, Italy
-
Merck Sharp & Dohme LLCActive, not recruitingHematological MalignanciesUnited States, Canada, Brazil, Chile, Denmark, France, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
AbbVieI-Mab Biopharma Co. Ltd.CompletedLymphoma | Solid TumorUnited States, China
-
ImmunityBio, Inc.Active, not recruitingMelanoma | Renal Cell Carcinoma | Cervical Cancer | Small Cell Lung Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Non-Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Merkel Cell Carcinoma | Microsatellite Instability | Mismatch Repair DeficiencyUnited States
-
Canadian Myeloma Research GroupMerck Sharp & Dohme LLCWithdrawn
-
Merck Sharp & Dohme LLCCompletedProstatic NeoplasmsUnited States, Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
-
Craig L Slingluff, JrNational Cancer Institute (NCI)Completed
-
Mirati Therapeutics Inc.TerminatedUrothelial Carcinoma Bladder | Urothelial Carcinoma | Urothelial Carcinoma Ureter | Urothelial Carcinoma of the Renal Pelvis and Ureter | Urothelial Carcinoma UrethraUnited States